🔴 Echo IQ is trading 61.72% down today after FDA finds EchoSolv HF not substantially equivalent

Echo IQ is trading 61.72% down at $0.49 after the FDA issued a Not Substantially Equivalent determination for its EchoSolv HF 510(k) application.

• EchoSolv HF is not cleared for commercial use, although the 510(k) pathway remains open.
• Echo IQ requested a trading halt pending the regulatory update and scheduled an investor webinar for September 9, 2026.
• EchoSolv AS and its U.S. commercialisation program remain unaffected.